"Clinical benefit rate" in phase 2 gynecologic cancer trials: implying more than the data support?

Gynecol Oncol. 2010 May;117(2):348-9. doi: 10.1016/j.ygyno.2010.01.004. Epub 2010 Feb 18.
No abstract available

MeSH terms

  • Clinical Trials, Phase II as Topic / methods*
  • Endpoint Determination
  • Female
  • Genital Neoplasms, Female / drug therapy*
  • Humans
  • Treatment Outcome